Translational Drug Development (TD2)
Don Sortillon is an experienced Clinical Data Manager currently employed by Translational Drug Development (TD2) since August 2022. Responsibilities include serving as the primary contact for sponsors and trial teams regarding trial data management activities, creating and adhering to timelines, and ensuring compliance with Good Clinical Practice (GCP) and ICH Guidelines. Previous roles include Clinical Data Manager at Spectrum Pharmaceuticals, Inc. where Don represented clinical data management in meetings and supported lead data management team members, and Research Coordinator II for the Children's Oncology Group, coordinating data management for trials. Additionally, Don has experience as a Quality Assurance/Quality Control Analyst at Auro Pharmaceuticals, a Forensic Identification Specialist with the Pasadena Police Department, and as a Researcher/Animal Caretaker at the University of La Verne. Educational qualifications include a Master’s degree in Biomedical Forensic Sciences from Boston University School of Medicine and a Bachelor’s degree in Biology from the University of La Verne.
This person is not in any offices
Translational Drug Development (TD2)
Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families. TD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGen’s deep scientific expertise and approach to interrogating the “omic” drivers of disease is at the heart of TD2’s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.